This observation, in agreement with our data, suggests that EZH2 is a critical epigenetic check point regulator preventing immunomodulatory macrophage differentiation/polarization and contributing to poor resolution of cardiac inflammation post-MI. Here, EZH2 is linked to myocardial infarction.